Table 5 |
|||
|
Multivariate model for the relative risk of parasite clearance |
|||
|
Variable |
Hazard ratio |
95% CI |
P |
|
|
|||
|
Treatment with AS/SP vs. SP |
1.8 |
1.4 – 2.3 |
<0.001 |
|
Log10 parasite density (per μl) blood) |
0.8 |
0.7 – 0.8 |
<0.001 |
|
Catuane (compared to other sites) |
1.8 |
1.3 – 2.5 |
<0.001 |
|
|
|||
|
SP: sulphadoxine-pyrimethamine AS/SP: artesunate/sulphadoxine-pyrimethamine |
|||
|
Allen et al. Malaria Journal 2009 8:141 doi:10.1186/1475-2875-8-141 |
|||
